Herpes Simplex Virus Genital Infection
Showing 1 - 25 of >10,000
Recurrent Genital Herpes Trial (UB-621)
Not yet recruiting
- Recurrent Genital Herpes
- UB-621
- (no location specified)
May 16, 2022
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed
- Neonatal Herpes Simplex Infection
- +7 more
-
Copenhagen, Denmark
- +1 more
Dec 25, 2022
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Suspended
- HSV-2 Infection
- Herpes Simplex Virus Infection
- Diagnostic Test: NOWDx HSV-2 Test
-
Tempe, Arizona
- +2 more
Sep 29, 2022
Treating Genital Herpes Infection to Reduce Racial Disparities
Not yet recruiting
- Genital Herpes Simplex
- +2 more
-
Oakland, CaliforniaDivision of Research, Kaiser Permanente Northern California
Jun 22, 2022
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)
Recruiting
- Virus
- +3 more
- Purell Hand Sanitizer
- Medical Grade Mineral Oil
-
Pocatello, Idaho
- +2 more
Nov 13, 2023
Knowledge of Young Adults About Genital Herpes
Recruiting
- Genital Herpes
- data collection
-
Reims, FranceFanny Bichon
Dec 29, 2022
HSV Infection Trial (walnut extract)
Completed
- HSV Infection
- walnut extract
- (no location specified)
Oct 16, 2023
Frequency of Symptomatic Herpes Virus I and II in HIV Infected
Recruiting
- HIV Disease
- +2 more
- Blood draw
-
Los Angeles, CaliforniaGlobal Research Institute
Apr 9, 2023
Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)
Recruiting
- Neonatal Herpes Simplex Infection
-
Birmingham, AlabamaUniversity of Alabama - Children's of Alabama
Sep 12, 2022
Herpes Simplex, Genital Trial in Belgium (2LHERP®, Placebo)
Recruiting
- Herpes Simplex, Genital
- 2LHERP®
- Placebo
-
Lodelinsart, Charleroi, Belgium
- +14 more
Dec 22, 2022
Herpes Labialis Trial in Germany (drug, behavioral, procedure)
Active, not recruiting
- Herpes Labialis
- HDIT101 (blinded therapy)
- +5 more
-
Berlin, Germany
- +4 more
Jan 26, 2023
Herpes Simplex-virus Type 1 (HSV-1) Reactivation
Recruiting
- Tracheobronchitis
- Herpes Simplex Infection
- Patients with herpes-simplex infection requiring bronchoscopy
-
Münster, GermanyUniversity Hospital Münster
Apr 11, 2022
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023